Identification of Specific miRNAs in Neutrophils of Type 2 Diabetic Mice: Overexpression of <i>miRNA-129-2-3p</i> Accelerates Diabetic Wound Healing

Abstract

Neutrophils are involved in the first stage of acute inflammation. After injury, they are mobilized and recruited to the injured tissue. In diabetes, wound healing is delayed and aberrant, leading to excessive recruitment and retention of neutrophils that fail to promote angiogenesis and prolong inflammation. However, the exact pathological mechanisms of diabetic-derived neutrophils in chronic inflammation remain unclear. Here, miRNA profiling of neutrophils from bone marrow in type 2 diabetic mice was performed using a microarray. miRNAs regulate the posttranscriptional expression of target mRNAs and are important in countering inflammation-related diseases. Our study revealed that miRNAs exhibit differential expression in diabetic-derived neutrophils compared with non-diabetic-derived neutrophils, especially <i>miR-129</i> family members. <i>miR-129-2-3p</i> directly regulated the translation of <i>Casp6</i> and <i>Ccr2</i>, which are involved in inflammatory responses and apoptosis. Furthermore, <i>miR-129-2-3p</i> overexpression at the wound site of type 2 diabetic mice accelerated wound healing. These results suggest possible involvement of <i>miR-129-2-3p</i> in diabetic-derived neutrophil dysfunction and that retention kinetics of neutrophils and chronic inflammation may be initiated through <i>miR-129-2-3p</i>-regulated genes. This study characterizes changes in global miRNA expression in diabetic-derived neutrophils and systematically identifies critical target genes involved in certain biological processes related to the pathology of diabetic wound healing.